Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

GlaxoSmithKline initiates first-in-human study of GSK-3358699

March 22, 2018

GlaxoSmithKline divulges novel bromodomain and extra-terminal protein inhibitors

March 22, 2018

TissueGene changes name to Kolon TissueGene

March 19, 2018

Patient enrollment ongoing in phase II study of BCD-089

March 16, 2018

Medshine Discovery patents new PDE4 inhibitors

March 15, 2018

Kezar Life Sciences initiates phase I/II study of KZR-616 in SLE

March 12, 2018

FDA grants regenerative medicine advanced therapy designation to AmnioFix

March 12, 2018

First-in-human results for Progenza in patients with knee osteoarthritis

March 12, 2018

FDA grants allowance of IND for FCX-013 gene therapy for scleroderma

March 7, 2018

EMA committee hands down positive opinion for Kineret in Still's disease

Feb. 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...